There is room for both biological and synthetic products in the market.
Patients/ medical experts already have a choice between the two, and there are many patients where biological products may be more suitable.
Why not have a product portfolio that offer both types of products.
The forecast revenue of ARX is not that far behind PNV for the next few years, proving that there is a market for biological products.
- Forums
- ASX - By Stock
- PNV
- Should PNV consider taking over ARX?
PNV
polynovo limited
Add to My Watchlist
4.51%
!
$1.17

Should PNV consider taking over ARX?, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.17 |
Change
-0.055(4.51%) |
Mkt cap ! $815.1M |
Open | High | Low | Value | Volume |
$1.23 | $1.23 | $1.17 | $2.186M | 1.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 32723 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 94061 | 51 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 57997 | 1.165 |
26 | 125736 | 1.160 |
13 | 234358 | 1.155 |
28 | 196772 | 1.150 |
7 | 49569 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 89079 | 50 |
1.175 | 74989 | 35 |
1.180 | 55287 | 14 |
1.185 | 61141 | 12 |
1.190 | 102369 | 9 |
Last trade - 14.30pm 07/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online